480 B.P. Nandeshwarappa et al.
The mixture was poured onto cold water (500 ml); the resulting solid product 5a was collected
by filtration, washed with ethanol, dried and recrystallized from ethyl acetate. Similarly, the
compounds 4b–e were prepared in 75–85% yields.
3.4.1. 1-Phenyl-2a, 7b-dihydroazeto[2ꢀ,3ꢀ:4,5]thieno[2,3-b]quinoline (6a)
◦
1
− −
−
Solid, 77%; mp 238 C; H NMR (300 MHz, DMSO-d6) δ (ppm): 4.96 (1H, s, N CH C), 5.89
(1H, s, S CH ), 7.35–8.60 (9H, m, Ar-H); IR (KBr) ν (cm−1): 1735.78 (C = O azetidinone),
[M+], 304. Calcd. (%) for C18H12N2OS: C, 71.03; H, 3.97; N, 9.20; S, 10.54. Found: C, 71.23;
H, 3.83; N, 9.40; S, 10.72.
− −
−
3.4.2. 1-(4-Methylphenyl)-2a,7b-dihydroazeto[2ꢀ,3ꢀ:4,5]thieno[2,3-b]quinoline (6b)
◦
1
−
Solid, 80%; mp 242 C; H NMR (300 MHz, DMSO-d6) δ (ppm): 2.60 (3H, s, CH3), 4.85 (1H,
s, N CH C), 5.78 (1H, s, S CH ), 7.37–8.50 (9H, m, Ar-H); IR (KBr) ν (cm−1): 1735.66
(C = O azetidinone), [M+], 318. Calcd. (%) for C19H14N2OS: C, 71.67; H, 4.43; N, 8.80; S,
10.07. Found: C, 71.49; H, 3.27; N, 8.69; S, 10.19.
− −
−
− −
−
3.4.3. 1-(4-Methoxyphenyl)-2a,7b-dihydroazeto[2ꢀ,3ꢀ:4,5]thieno[2,3-b]quinoline (6c)
◦
1
−
Solid, 85%; mp 269 C; H NMR (300 MHz, DMSO-d6) δ (ppm): 3.90 (3H, s, OCH3), 4.85
(1H, s, N CH C), 5.68 (1H, s, S CH ), 7.29–8.45 (9H, m, Ar-H); IR (KBr) ν (cm−1):
1738.64 (C = O azetidinone), [M+], 334. Calcd. (%) for C19H14N2O2S: C, 68.24; H, 4.22; N,
8.38; S, 9.59. Found: 68.12, H, 4.39; N, 8.26; S, 9.44.
− −
−
− −
−
3.4.4. 1-(4-Chlorophenyl)-2a, 7b-dihydroazeto[2ꢀ,3ꢀ:4,5]thieno[2,3-b]quinoline (6d)
◦
1
− −
−
Solid, 78%; mp 275 C; H NMR (300 MHz, DMSO-d6) δ (ppm): 4.80 (1H, s, N CH C), 5.73
(1H, s, S CH ), 7.34–8.55 (9H, m, Ar-H); IR (KBr) ν (cm−1): 1738.61 (C = O azetidinone),
[M+], 338. Calcd. (%) for C18H11ClN2OS: C, 63.81; H, 3.27; N, 8.27; S, 9.46. Found: C, 63.69;
H, 3.12; N, 8.15; S, 9.34.
− −
−
3.4.5. 1-(4-Nitrophenyl)-2a,7b-dihydroazeto[2ꢀ,3ꢀ:4,5]thieno[2,3-b]quinoline (6e)
◦
1
− −
−
Solid, (75%); mp. 285 C; H NMR (300 MHz, DMSO-d6) δ (ppm): 4.68 (1H, s, N CH C),
5.70 (1H, s, S CH ), 7.30–8.60 (9H, m, Ar-H). IR (KBr) ν (cm−1): 1738.64 (C = O azetidi-
none), [M+], 349. Calcd. (%) for C18H11N3O3S: C, 61.88; H, 3.17; N, 12.03; S, 9.18. Found: C,
61.74; H, 3.34; N, 12.24; S, 9.36.
− −
−
References
(1) Michael, J.P. Nat. Prod. Rep.1997, 14, 605–611. (b) Balasubramanian, M.; Keay, J.G. In Comprehensive Heterocyclic
Chemistry II, Katrizky, A.R., Rees, C.W., Scriven, E.F.V., Eds. Pergamon Press: Oxford, 1996, Vol. 5, Chapter 5,
p 245.
(2) Meghraby, E.L.; Haroun, B.; Mohamed. Egypt. J. Pharm. Sci. 1982, 23, 327–336; Chem. Abstr. 1985, 102, 149024a.
(3) Drayton, C.J. Comprehensive Medicinal Chemistry; Pergamon Press: Oxford, UK, 1990; Ed. I., Vol. 6, p 877.
(4) Ramanathan, J.C.; Namboothiri, D.G. J. Indian Chem. Soc. 1978, 55, 822.
(5) Shafeeque, S.; Mohan, S.; Manjunatha, K.S. Indian J. Heterocycl. Chem. 1999, 8, 297.
(6) Srinivas Raju, V.; Mohan, S.; Saravanan, J. Indian J. Heterocycl. Chem. 1998, 8, 59–62.
(7) Modica, M.; Santagati, M.; Russo, F.; Parotti, L.; Gioia De, L.; Selvaggini, C.; Salmona, M.; Mennini, T. J. Med.
Chem. 1997, 40, 574–585.